-
-
-
-
-
-
-
Clearmind Medicine receives U.S. patent for binge behavior compound
-
-
-
-
-
-
-
Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment
-
-
-
-
-
-
-
Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.
-
-
-
-
-
-
-
Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation
-
-
-
-
-
-
-
Clearmind Medicine's CMND-100 meets primary endpoint in phase trial
-
-
-
-
-
-
-
Clearmind Medicine secures six Hong Kong patents for psychedelic combinations
-
-
-
-
-
-
-
Clearmind Medicine receives international patent for weight loss therapy
-
1,165,871 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

